Most people taking leflunomide start noticing improvement in joint pain, swelling, and stiffness within 4 to 8 weeks. Full benefits continue building over several months, with the strongest results typically appearing around the 6-month mark. That timeline can feel slow when you’re dealing with daily pain, but the delay is built into how the drug works.
What to Expect in the First Few Months
The earliest signs of improvement usually show up around week 4. For some people, it takes closer to 8 weeks before anything feels noticeably different. These early changes are often subtle: slightly less morning stiffness, a bit less swelling, or the ability to do things that were painful a few weeks earlier.
By 12 weeks, clinical trial data shows that roughly 63% of patients achieve a meaningful reduction in symptoms (at least a 20% improvement in joint tenderness, swelling, and other measures). That number continues climbing. By 24 weeks, about 67% of patients reach that same threshold, and response rates in real-world studies run even higher, with over 80% of patients showing significant improvement by the 6-month point. Around 40% of patients achieve a 50% or greater improvement at 3 months, and about 18% reach 70% improvement in that same timeframe.
So if you’re a few weeks in and feeling discouraged, the odds are still in your favor. The drug keeps accumulating benefit well past the initial response window.
Why It Takes Weeks to Kick In
Leflunomide doesn’t work like a painkiller that dulls symptoms within hours. It targets the immune cells driving joint inflammation, specifically the overactive white blood cells (lymphocytes) that attack your joint tissue in rheumatoid arthritis.
These immune cells need a massive supply of building blocks called pyrimidines to multiply. When they become activated, they ramp up their pyrimidine production by about eightfold. Leflunomide’s active form blocks a key enzyme in that production line, starving these cells of the raw materials they need to replicate. Over time, the population of overactive immune cells shrinks, and inflammation gradually drops.
The other reason for the slow onset is pharmacokinetics. Once leflunomide is absorbed, your body converts it into an active compound with an unusually long half-life of about 19 days. That means it takes weeks for the drug to build up to its full working concentration in your bloodstream. You’re essentially filling a reservoir, and the therapeutic effects don’t peak until that reservoir is full.
Loading Doses Don’t Speed Things Up
Some prescribers start leflunomide with a “loading dose,” giving 100 mg per day for the first 3 days before dropping to the standard 20 mg daily maintenance dose. The logic is that a higher initial dose might fill that reservoir faster and get the drug working sooner.
In practice, loading doses don’t appear to help. Clinical trials comparing a 3-day loading dose to simply starting on 20 mg found no meaningful difference in how quickly patients improved. In one study, the group that skipped the loading dose actually had a higher response rate at 3 months (78% versus 59%). Loading doses were also linked to more side effects early on, particularly gastrointestinal problems and diarrhea. Many rheumatologists now skip the loading dose entirely and start patients on the maintenance dose from day one.
What Influences Your Response Time
The 4-to-8-week window is a general range, and individual timelines vary. People with early-stage rheumatoid arthritis, meaning shorter disease duration and less established joint damage, tend to respond well. In studies of patients with early disease, response rates at 6 months exceeded 80%, regardless of whether they received a loading dose.
Your response also depends on how active your disease is when you start. People with highly active inflammation sometimes notice the contrast more quickly, while those with lower-grade symptoms may find the improvement more gradual and harder to pinpoint. Other factors like your overall health, whether you’re taking leflunomide alone or alongside other treatments, and how consistently you take the daily dose all play a role.
If you’ve reached the 3-month mark with no noticeable change, that’s a reasonable point to talk with your rheumatologist about next steps. Some people simply don’t respond to leflunomide, and waiting beyond 12 weeks without any benefit is unlikely to produce a sudden turnaround.
Blood Tests During the Wait
While you’re waiting for leflunomide to take effect, expect regular blood draws. Liver enzyme testing is recommended before starting the drug, then monthly for the first 6 months, and every other month after that. Leflunomide is processed through the liver, and in a small percentage of patients it can cause enzyme elevations that signal liver stress.
These lab visits also give your doctor objective data on inflammation markers, which sometimes improve before you feel a subjective difference in your joints. If your blood work shows declining inflammation at week 6 but you don’t feel much different yet, that’s actually a good sign that the drug is working and the clinical benefits are on their way.
If You Need to Stop
That long half-life cuts both ways. While it helps maintain steady drug levels (meaning a missed dose here and there won’t cause a flare), it also means leflunomide lingers in your body for a long time after you stop taking it. Without intervention, it can take months for the active compound to fully clear your system. If you need to stop quickly, for pregnancy planning or due to side effects, your doctor can use a washout procedure with cholestyramine or activated charcoal, which shortens the clearance time from weeks to just a few days.